SES/NORTHSTAR
31.3.2022 08:52:11 CEST | Business Wire | Press release
A partnership to enhance Space Situational Awareness (SSA) and ensure a sustainable use of space has been formed between SES, the world’s leading satellite-based content connectivity solutions provider, and NorthStar Earth and Space (NorthStar), the first commercial service to monitor space from space, both companies announced today.
Together with NorthStar, the teams will be working to launch, develop and evolve NorthStar’s SSA products tailored to benefit SES’s satellite operations and fleet management. NorthStar will deliver unique SSA services to help satellite operators with safer management of their fleets, minimization of collision risks, and development of space sustainability solutions. Fuelled by data gathered in space, NorthStar’s next-generation service will provide a unique layer of information to improve operational performance for all satellite operators and contribute to the realization of a more sustainable space environment.
SES has recently announced its revised Environment, Social and Governance (ESG) strategy and is a firm believer of how sustainable space meets sustainable Earth. Its new ESG strategy revolves around four key pillars – ensuring the secure and sustainable use of space; embarking bold climate action, increasing diversity and inclusion in the industry; and using its global content connectivity solutions to meet critical human needs.
"Space supports critical infrastructure for our economy. NorthStar’s collaboration with SES leads to more responsible and sustainable operations in space from all stakeholders. NorthStar’s high performance SSA services combined with SES’s leading role in the industry brings a necessary focus towards the increasingly unmanageable risks we are all witnessing in space”, said Stewart Bain, CEO & Founder of NorthStar Earth & Space. "This is a major step in NorthStar’s integration and growth within the fast-moving Luxembourg space ecosystem. Recent investment from the LFF and support from the Luxembourg Ministry of the Economy also contribute to accelerate NorthStar services in support of this important collaboration.”
“We are excited to partner with NorthStar and leverage their expertise in space-based sensors to monitor traffic in space and the accuracy of their intelligent platform to transmit information faster,” said Steve Collar, CEO of SES. “Space sustainability is of fundamental importance to SES and to the industry. The industry needs to come together quickly to protect space for future generations before it’s too late and our partnership with NorthStar is a strong step in that direction.”
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
Read our Blogs >
Visit the Media Gallery >
About North Star
NorthStar Earth & Space is headquartered in Montréal, Canada. NorthStar has recently launched its European headquarters in Luxembourg with the support of the Luxembourg Future Fund. NorthStar also has an office in Washington D.C. NorthStar seeks to empower humanity to preserve our planet through a unique Space and Earth information & intelligence platform using space-based sensors. NorthStar strives to help transform the way governments, industry and institutions assess risk, enforce regulations and make decisions to foster the sustainable development of our planet and deliver a safe and secure near-Earth environment. NorthStar’s unique space-based commercial Space Situational Awareness products address many of the critical and immediate challenges facing all satellite operators. With a comprehensive view of all near-Earth orbits, NorthStar’s satellites will deliver more frequent and precise observations of resident space objects than any current system. Through a suite of high-speed decision quality information services derived from its unparalleled coverage, object custody, and enhanced predictive analytics NorthStar generates its Space Information & Intelligence services.
NorthStar’s investors comprise a global coalition of strategic partners, including Telesystem Space (a co-enterprise of the Sirois family office, Telesystem and the Roger’s Family Trust of Canada), the Space Alliance (Thales Alenia Space and Telespazio) of Europe, the Government of Quebec, the Government of Canada and the Luxembourg Future Fund. More information: https://northstar-data.com/
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,400 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220330005906/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
